Presentation NY Valves 2025 SAVR vs. TAVR Strategy Trials (PARTNER 3 and RHEIA) Presenter: Didier Tchetche June 27, 2025
Presentation NY Valves 2025 30-Day Outcomes of the Lux-Plus TTVR System in Large Tricuspid Annuli in the TRINITY Trial Presenter: Thomas Elie Modine June 25, 2025
Presentation NY Valves 2025 SIEGEL TAVR: FIH 1 year & US Early Feasibility 30 Day Results Presenter: Pradeep K. Yadav June 25, 2025
Presentation NY Valves 2025 PRO – SURGERY: 3 Reasons Why Surgery Is the Best Option for This Patient Presenter: Christine J. Chung June 25, 2025
Presentation NY Valves 2025 PRO – TAVR: 3 Reasons Why TAVR Is the Best Option for This Patient Presenter: Isaac George June 25, 2025
News Conference News NY Valves 2024 National Data Point to Soaring TAVI Rates in Patients Under 65 Michael O'Riordan June 14, 2024
Presentation NY Valves 2024 Partner Valves: Role of a Prospective Device Selection Strategy Using Acurate and SAPIEN 3 as Complementary Devices in Transcatheter Aortic Valve Replacement Presenter: Jonathan Michel June 07, 2024
News Conference News NY Valves 2024 Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli Michael O'Riordan June 05, 2024